231 related articles for article (PubMed ID: 30988397)
1. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury.
Krishna-Subramanian S; Singer S; Armaka M; Banales JM; Holzer K; Schirmacher P; Walczak H; Kollias G; Pasparakis M; Kondylis V
Cell Death Differ; 2019 Dec; 26(12):2710-2726. PubMed ID: 30988397
[TBL] [Abstract][Full Text] [Related]
2. OTUB1 prevents lethal hepatocyte necroptosis through stabilization of c-IAP1 during murine liver inflammation.
Koschel J; Nishanth G; Just S; Harit K; Kröger A; Deckert M; Naumann M; Schlüter D
Cell Death Differ; 2021 Jul; 28(7):2257-2275. PubMed ID: 33712742
[TBL] [Abstract][Full Text] [Related]
3. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
[TBL] [Abstract][Full Text] [Related]
4. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.
Van TM; Polykratis A; Straub BK; Kondylis V; Papadopoulou N; Pasparakis M
J Clin Invest; 2017 Jun; 127(7):2662-2677. PubMed ID: 28628031
[TBL] [Abstract][Full Text] [Related]
5. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
[TBL] [Abstract][Full Text] [Related]
6. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
[TBL] [Abstract][Full Text] [Related]
7. RIPK1 protects hepatocytes from death in Fas-induced hepatitis.
Filliol A; Farooq M; Piquet-Pellorce C; Genet V; Dimanche-Boitrel MT; Vandenabeele P; Bertrand MJM; Samson M; Le Seyec J
Sci Rep; 2017 Aug; 7(1):9205. PubMed ID: 28835677
[TBL] [Abstract][Full Text] [Related]
8. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.
Dannappel M; Vlantis K; Kumari S; Polykratis A; Kim C; Wachsmuth L; Eftychi C; Lin J; Corona T; Hermance N; Zelic M; Kirsch P; Basic M; Bleich A; Kelliher M; Pasparakis M
Nature; 2014 Sep; 513(7516):90-4. PubMed ID: 25132550
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Notch1 inhibits TAK1 function and RIPK3-mediated hepatocyte necroptosis through activation of β-catenin signaling in liver ischemia and reperfusion injury.
Xu D; Qu X; Tian Y; Jie Z; Xi Z; Xue F; Ma X; Zhu J; Xia Q
Cell Commun Signal; 2022 Sep; 20(1):144. PubMed ID: 36114543
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
11. TAB2 deficiency induces dilated cardiomyopathy by promoting RIPK1-dependent apoptosis and necroptosis.
Yin H; Guo X; Chen Y; Zeng Y; Mo X; Hong S; He H; Li J; Steinmetz R; Liu Q
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 34990405
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
14. RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development.
Zhang X; Dowling JP; Zhang J
Cell Death Dis; 2019 Mar; 10(3):245. PubMed ID: 30867408
[TBL] [Abstract][Full Text] [Related]
15. Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis.
Farooq M; Filliol A; Simoes Eugénio M; Piquet-Pellorce C; Dion S; Raguenes-Nicol C; Jan A; Dimanche-Boitrel MT; Le Seyec J; Samson M
Cell Death Dis; 2019 Jan; 10(1):12. PubMed ID: 30622241
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis.
Newton K; Wickliffe KE; Dugger DL; Maltzman A; Roose-Girma M; Dohse M; Kőműves L; Webster JD; Dixit VM
Nature; 2019 Oct; 574(7778):428-431. PubMed ID: 31511692
[TBL] [Abstract][Full Text] [Related]
17. RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis.
Filliol A; Piquet-Pellorce C; Raguénès-Nicol C; Dion S; Farooq M; Lucas-Clerc C; Vandenabeele P; Bertrand MJM; Le Seyec J; Samson M
J Hepatol; 2017 Jun; 66(6):1205-1213. PubMed ID: 28088582
[TBL] [Abstract][Full Text] [Related]
18. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease.
Malireddi RKS; Gurung P; Kesavardhana S; Samir P; Burton A; Mummareddy H; Vogel P; Pelletier S; Burgula S; Kanneganti TD
J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31869420
[TBL] [Abstract][Full Text] [Related]
19. TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma.
Podder B; Guttà C; Rožanc J; Gerlach E; Feoktistova M; Panayotova-Dimitrova D; Alexopoulos LG; Leverkus M; Rehm M
Cell Death Differ; 2019 Dec; 26(12):2520-2534. PubMed ID: 30850732
[TBL] [Abstract][Full Text] [Related]
20. RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl
Hameed H; Farooq M; Vuillier C; Piquet-Pellorce C; Hamon A; Dimanche-Boitrel MT; Samson M; Le Seyec J
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
